Premium
‘Delisting’ OxyContin® to reduce prescription opioid‐related harms in Ontario (Canada)—gauging effects 5 years later
Author(s) -
Fischer Benedikt,
Vojtila Lenka,
Kurdyak Paul
Publication year - 2017
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.4253
Subject(s) - mental health , addiction , medical prescription , medicine , addiction medicine , psychiatry , family medicine , nursing
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom